| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| fludrocortisone | androgen receptor | NA | Successful target | TTD , DGIDB | Adrenogenital Syndrome[MeSHID:D047808] Addison Disease[MeSHID:D000224] Hypoaldosteronism[MeSHID:D006994] Neoplasm Metastasis[MeSHID:D009362] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Wasting Syndrome[MeSHID:D019282] |
0.15 | approved | unknown |
| fludrocortisone | glucocorticoid receptor | small molecule | NA | drugbank | Adrenogenital Syndrome[MeSHID:D047808] Addison Disease[MeSHID:D000224] Hypoaldosteronism[MeSHID:D006994] Neoplasm Metastasis[MeSHID:D009362] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Wasting Syndrome[MeSHID:D019282] |
NA | approved,investigational | agonist |
| fludrocortisone | mineralocorticoid receptor | small molecule | Successful target | TTD , drugbank , DGIDB | Adrenogenital Syndrome[MeSHID:D047808] Addison Disease[MeSHID:D000224] Hypoaldosteronism[MeSHID:D006994] Neoplasm Metastasis[MeSHID:D009362] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Wasting Syndrome[MeSHID:D019282] |
16.6 | approved,investigational | agonist |
| click here to return to the previous page | ||||||||